Skip to content

Study · Not a test of the peptide alone · 1996

2 results

[The use of the HPLC method for the quantitative determination of a peptide analog of piracetam with nootropic activity and its main metabolites].

Boĭko SS, Zherdev VP, Gudasheva TA, Vasilevich NI, Ostrovskaia RU, Voronina TA, Rozantsev GG

Eksperimental'naia i klinicheskaia farmakologiia1 Mar 1996Cited by 2 (Europe PMC)

PMID8974563 (opens in a new tab)PepBankPUB-08974563
Publisher pageAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, Noopept (omberacetam) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Noopept (omberacetam).

  1. 01LabNot a test of Noopept (omberacetam) aloneIn vitro (cell-free)Pharmacokinetics

    In rat model experiments, plasma enzymes metabolized GVS-111 during 1-h incubation and formed phenylacetylproline.

    In plain wordsIn lab tests with rat material, plasma enzymes metabolized GVS-111 and formed phenylacetylproline.

    Peptide
    Noopept (omberacetam)
    Outcome
    Not applicablePlasma enzymatic metabolism
    Study

    ratn: not reported in source

    Rat plasma and liver enzymes
    Outcome group
    Pharmacokinetics · Pharmacology

    Source sentences

    Summary
    In the model experiments on rats the enzymes of blood plasma were shown to metabolize GVS-111 during 1-h incubation with the formation of metabolite, phenylacetylproline.

    In this study, Noopept (omberacetam) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Noopept (omberacetam).

  2. 02LabNot a test of Noopept (omberacetam) aloneIn vitro (cell-free)Pharmacokinetics

    In rat model experiments, liver tissue enzymes metabolized GVS-111 much more slowly than plasma enzymes.

    In plain wordsIn lab tests with rat material, liver enzymes metabolized GVS-111 more slowly than plasma enzymes.

    Peptide
    Noopept (omberacetam)
    Outcome
    DecreaseLiver enzymatic metabolism rate
    Study

    ratn: not reported in source

    Rat plasma and liver enzymes
    Comparator
    Blood plasma enzymes
    Outcome group
    Pharmacokinetics · Pharmacology

    Source sentences

    Summary
    The liver tissue enzymes metabolized GVS-111 much slower.
    1 context sentence
    Summary · context
    In the model experiments on rats the enzymes of blood plasma were shown to metabolize GVS-111 during 1-h incubation with the formation of metabolite, phenylacetylproline.

    In this study, Noopept (omberacetam) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Noopept (omberacetam).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 12:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.